小柯机器人

研究揭示肝脏对钠依赖性胆盐吸收的结构基础
2022-05-15 14:20

法国波尔多大学Nicolas Reyes课题组揭示肝脏对钠依赖性胆盐吸收的结构基础。相关论文发表在2022年5月11日在线发表在《自然》杂志上。

研究人员展示了人类Na+-牛磺胆酸盐共转运多肽(NTCP)与纳米抗体复合物的冷冻电镜结构,从而揭示了其运输周期的关键构象。NTCP经历了一个构象转变,打开了一个宽的跨膜孔,作为胆盐的运输途径,并暴露了人类乙型和丁型肝炎病毒(HBV/HDV)结合到细胞外的关键决定性残基。一种稳定孔隙关闭和朝内状态的纳米抗体损害了对HBV/HDV受体结合结构域preS1的识别,进而证明了病毒对NTCP运输循环中由内向外开放的构象的结合选择性。这些结果提供了对NTCP"门孔"运输和HBV/HDV受体识别机制的分子见解,并有望帮助开发针对NTCP的肝病疗法。
 
据了解,肝脏从血液中吸收胆盐以产生胆汁,使亲脂性营养物质得以吸收,代谢物和药物得以排泄。人类NTCP是肝脏中主要的胆盐吸收系统。NTCP也是HBV/HDV的细胞进入受体,并已成为抗病毒药物的一个重要靶点。然而,对NTCP运输和病毒受体功能的分子机制仍不完全了解。
 
附:英文原文
 
Title: Structural basis of sodium-dependent bile salt uptake into the liver

Author: Goutam, Kapil, Ielasi, Francesco S., Pardon, Els, Steyaert, Jan, Reyes, Nicolas

Issue&Volume: 2022-05-11

Abstract: The liver takes up bile salts from blood to generate bile, enabling absorption of lipophilic nutrients and excretion of metabolites and drugs1. Human Na+–taurocholate co-transporting polypeptide (NTCP) is the main bile salt uptake system in liver. NTCP is also the cellular entry receptor of human hepatitis B and D viruses2,3 (HBV/HDV), and has emerged as an important target for antiviral drugs4. However, the molecular mechanisms underlying NTCP transport and viral receptor functions remain incompletely understood. Here we present cryo-electron microscopy structures of human NTCP in complexes with nanobodies, revealing key conformations of its transport cycle. NTCP undergoes a conformational transition opening a wide transmembrane pore that serves as the transport pathway for bile salts, and exposes key determinant residues for HBV/HDV binding to the outside of the cell. A nanobody that stabilizes pore closure and inward-facing states impairs recognition of the HBV/HDV receptor-binding domain preS1, demonstrating binding selectivity of the viruses for open-to-outside over inward-facing conformations of the NTCP transport cycle. These results provide molecular insights into NTCP ‘gated-pore’ transport and HBV/HDV receptor recognition mechanisms, and are expected to help with development of liver disease therapies targeting NTCP.

DOI: 10.1038/s41586-022-04723-z

Source: https://www.nature.com/articles/s41586-022-04723-z

Nature:《自然》,创刊于1869年。隶属于施普林格·自然出版集团,最新IF:69.504
官方网址:http://www.nature.com/
投稿链接:http://www.nature.com/authors/submit_manuscript.html


本期文章:《自然》:Online/在线发表

分享到:

0